Skip to main content
OpenTrials

Clinical trial condition

Adenocarcinoma

Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.

5,040 public trials 1,178 recruiting studies
Refine in advanced search Browse all conditions

Adenocarcinoma trial results

Completed

A Study of Ramucirumab (LY3009806) in Participants With Advanced Liver Cancer

NCT02069041

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Tainan, Taiwan
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taipei, Taiwan
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Taoyuan City, Taiwan
View Trial Details
Completed

Sorafenib Combined With Chemotherapy for Renal Collecting Duct Carcinoma

NCT01762150

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Sun Yat-sen university cancer center Guangzhou, Guangdong, China
  • Shenyang general hospital of Shenyang military command Shenyang, Liaoning, China
  • Xijing Hospital Xi’an, Shanxi, China
View Trial Details
Completed

hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse

NCT02960594

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Cancer, +53 more
Locations
  • Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • University of North Carolina Chapel Hill, North Carolina, United States
  • University of Pennsylvania Philadelphia, Pennsylvania, United States
View Trial Details
Completed

A Clinical Study to Assess Safety and Efficacy of a Tumor Vaccine in Patients With Advanced Renal Cell Carcinoma (ASET)

NCT01265368

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations
  • Charité - Universtitäsmedizin Berlin, Klinik für Urologie Berlin, Germany
  • Universitätsklinikum Bonn, Med. Klinik und Poliklinik, Hämatologie und Onkologie Bonn, Germany
  • Medizinische Hochschule Hannover, Klinik für Hämatologie, Hämostaseologie, Onkologie und Stammzelltransplantation OE6860 Hanover, Germany
View Trial Details
Completed

Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer

NCT00378703

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Providence Hospital Mobile, Alabama, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • The University of Arizona Medical Center-University Campus Tucson, Arizona, United States
View all 559 locations
View Trial Details

Related conditions